Results 101 to 110 of about 3,129 (177)
Some of the next articles are maybe not open access.
Current Opinion in Critical Care, 2004
Vasopressin is one of the most important endogenously released stress hormones during shock. In this review, studies published in the past year that add to our understanding of the use of vasopressin in the ICU are discussed.Endogenous vasopressin levels are inappropriately low in adults with severe sepsis but not in children with meningococcal septic ...
Cheryl L, Holmes, Keith R, Walley
openaire +2 more sources
Vasopressin is one of the most important endogenously released stress hormones during shock. In this review, studies published in the past year that add to our understanding of the use of vasopressin in the ICU are discussed.Endogenous vasopressin levels are inappropriately low in adults with severe sepsis but not in children with meningococcal septic ...
Cheryl L, Holmes, Keith R, Walley
openaire +2 more sources
Vasopressin and Vasopressin Antagonists in Heart Failure
2017Despite the introduction of multiple new pharmacological agents over the past three decades in the field of heart failure (HF), overall prognosis remains poor. Hyponatremia is prevalent in HF patients and has been suggested as a contributor to poor response to standard therapy.
Julie K, Vishram-Nielsen +1 more
openaire +2 more sources
Journal of Pharmacology and Experimental Therapeutics, 1980
Arginine vasopressin (AVP) stimulates renal prostaglandin (PG) production which is thought to inhibit vasopressins' antidiuretic action. Using rat renal medullary cells in culture (RMIC), we compared the ability of the following peptides which possess ...
T. Beck, A. Hassid, M. Dunn
semanticscholar +1 more source
Arginine vasopressin (AVP) stimulates renal prostaglandin (PG) production which is thought to inhibit vasopressins' antidiuretic action. Using rat renal medullary cells in culture (RMIC), we compared the ability of the following peptides which possess ...
T. Beck, A. Hassid, M. Dunn
semanticscholar +1 more source
Renal microvascular effects of vasopressin and vasopressin antagonists
American Journal of Physiology-Renal Physiology, 1989The effects of vasopressin (AVP) and vasopressin antagonists on lumen diameters of cortical afferent and efferent arterioles isolated from rabbit kidneys were examined. Over a concentration range of 10(-14) to 10(-7) M, AVP had no effect on lumen diameters of afferent arterioles, although the arterioles were responsive to norepinephrine.
R M, Edwards, W, Trizna, L B, Kinter
openaire +2 more sources
Vasopressin and Vasopressin Receptor Antagonists in Heart Failure
Cardiology in Review, 2009Antidiuretic hormone, also known as arginine vasopressin, is a hormone with a multitude of physiologic activities including the control of urinary free water excretion. Antidiuretic hormone also plays a role in vasoconstriction and has 3 receptors that have been identified.
Gerard, Oghlakian, Marc, Klapholz
openaire +2 more sources
Vasopressin and vasopressin antagonists in heart failure and hyponatremia
Current Heart Failure Reports, 2008Increased synthesis of arginine vasopressin (AVP) plays a critical role in fluid retention and hyponatremia in patients with heart failure. The AVP receptor antagonists constitute a new class of agents that are promising in the management of hyponatremia and congestion.
Dimitrios, Farmakis +3 more
openaire +2 more sources
Mechanisms of Vasopressin Secretion
Hormone Research, 1992The magnocellular vasopressin system of the rat has been studied intensively in recent years. This review outlines the electrophysiological characteristics of vasopressin neurons, the characteristics of stimulus-secretion coupling in the neural lobe, and describes some of the major features of the neural regulation of this system which underlie ...
Leng, G. +2 more
openaire +3 more sources
Trends in Endocrinology & Metabolism, 2000
The biological effects of arginine vasopressin (AVP) are mediated by three receptor subtypes: the V1a and V1b receptors that activate phospholipases via Gq/11, and the V2 receptor that activates adenylyl cyclase by interacting with Gs. Isolation of the cDNAs encoding the V1a and V1b receptor subtypes explained the tissue variability of V1 antagonist ...
openaire +2 more sources
The biological effects of arginine vasopressin (AVP) are mediated by three receptor subtypes: the V1a and V1b receptors that activate phospholipases via Gq/11, and the V2 receptor that activates adenylyl cyclase by interacting with Gs. Isolation of the cDNAs encoding the V1a and V1b receptor subtypes explained the tissue variability of V1 antagonist ...
openaire +2 more sources
Vasopressin metabolites: A link between vasopressin and memory?
1999The effects of endogenous metabolites of the neuropeptide vasopressin (VP) in behavioural tests led to the hypothesis that VP metabolites have a more selective function than VP. In contrast to VP, no peripheral effects have been found thus far with VP metabolites and their function seems to be associated with memory-related behaviour.
L G, Reijmers +4 more
openaire +2 more sources
Vasopressin in Cardiovascular Control: Role of Circulating Vasopressin
Clinical Science, 1984Vasopressin has been shown to elicit vasoconstriction in unanaesthetized animals at plasma concentrations similar to those associated with its renal antidiuretic effect. The vasconstrictor effects of vasopressin do not normally translate into pressor responses until relatively high plasma concentrations are reached.
openaire +3 more sources